By ANI
New Delhi: The Bharat Biotech International Limited has sent a proposal to the Drugs Controller General of India (DCGI) for conducting th...Read More
By Sanjay Jog
Mumbai: In an exclusive interview with The Free Press Journal, Dr Shashank Joshi, member of the state's Covid-19 task force explains the ...Read More
By ANI
New Delhi: As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelle...Read More
By PTI
The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India, according to the filing.
By PTI
New Delhi: Bharat Biotech, which had sought DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been...Read More
By PTI
New Delhi: Drugs Controller General of India (DCGI) Dr V G Somani on Tuesday gave permission to Serum Institute of India to resume clinic...Read More
By Sanjay Jog
The Maharashtra government, which is struggling to curb the COVID-19 pandemic, has decided to procure Itolizumab (a monoclonal antibody) ...Read More
By Sanjay Jog
Mumbai: Itolizumab (rDNA origin), a monoclonal antibody which was already approved for severe chronic plaque psoriasis, has now been gran...Read More